trial_id	trial_label	ae_code	ae_kg_id	ae_label	probability
trial_1	placebo	78	KG00099326	Hypertensive diseases	0.1834663450717926
trial_1	placebo	87	KG00098599	diarrhoea	0.17378847301006317
trial_1	placebo	189	KG00101580	Alanine aminotransferase increase	0.133098766207695
trial_1	placebo	177	KG00099299	hyperglycaemia	0.13145799934864044
trial_1	placebo	123	KG00099351	hypokalaemia	0.11817364394664764
trial_1	placebo	188	KG00101579	Aspartate aminotransferase increase	0.11181146651506424
trial_1	placebo	17	KG00097991	Asthenia NOS	0.1094527468085289
trial_1	placebo	173	KG00098172	Bronchopneumonia NOS	0.1074075773358345
trial_1	placebo	46	KG00099121	Headache NOS	0.09709885716438293
trial_1	placebo	9	KG00098432	Confusion NOS	0.0965469628572464
trial_1	placebo	21	KG00098675	dyspnoea	0.09582971781492233
trial_1	placebo	20	KG00098540	dehydration	0.09356392174959183
trial_1	placebo	228	KG00114657	Weight below normal	0.08837125450372696
trial_1	placebo	37	KG00097696	Cramps, Abdominal	0.08522957563400269
trial_1	placebo	350	KG00106765	decreased platelet count	0.08409801870584488
trial_1	placebo	2	KG00100772	thrombocytopaenia	0.08269296586513519
trial_1	placebo	29	KG00099354	hyponatraemia	0.08205243200063705
trial_1	placebo	67	KG00098673	Dyspepsia, NOS	0.07863903045654297
trial_1	placebo	49	KG00099902	nausea with vomiting	0.0780855119228363
trial_1	placebo	14	KG00097852	Anemia NOS	0.07505201548337936
trial_1	placebo	193	KG00108982	WHITE BLOOD CELL COUNT DECREASED	0.07463408261537552
trial_1	placebo	64	KG00097734	Acrodermatitis, NOS	0.06986873596906662
trial_1	placebo	68	KG00099901	nauseas	0.0689842700958252
trial_1	placebo	79	KG00100317	Insomnia, Primary	0.06874091923236847
trial_1	placebo	200	KG00098539	Disorders, Deglutition	0.06516055017709732
trial_1	placebo	114	KG00098933	fevers	0.06057475879788399
trial_1	placebo	194	KG00110727	Neutrophil Count Decreased	0.05878191441297531
trial_1	placebo	179	KG00099342	hypocalcaemia	0.058149635791778564
trial_1	placebo	77	KG00098450	Constipation NOS	0.05789849907159805
trial_1	placebo	151	KG00098274	Infarction, Cerebral	0.05732134357094765
trial_1	placebo	76	KG00100450	Respiratory insufficiency, NOS	0.057153794914484024
trial_1	placebo	86	KG00098565	Depression, Mental	0.05582801625132561
trial_1	placebo	104	KG00097963	arthralgias	0.05416206270456314
trial_1	placebo	126	KG00100076	Pain NOS	0.05359792709350586
trial_1	placebo	85	KG00098474	coughs	0.05309704318642616
trial_1	placebo	27	KG00099303	hyperkalaemia	0.05261848866939545
trial_1	placebo	61	KG00099501	Chronic Kidney Failure	0.05155130848288536
trial_1	placebo	101	KG00097901	Anorexia NOS	0.05003172159194946
trial_1	placebo	239	KG00100128	pareses	0.049842718988657
trial_1	placebo	243	KG00100947	Micturition frequency increased	0.049513667821884155
trial_1	placebo	180	KG00099363	Hypotension NOS	0.04909190908074379
trial_1	placebo	96	KG00101679	Unattended death NOS	0.0478878989815712
trial_1	placebo	30	KG00099500	Acute Kidney Failure	0.047357793897390366
trial_1	placebo	261	KG00101559	raised alkaline phosphatase	0.04383191466331482
trial_1	placebo	28	KG00099347	hypoglycaemia	0.04317861422896385
trial_1	placebo	5	KG00099169	haematuria	0.04174870625138283
trial_1	placebo	122	KG00099321	Hypersensitivity NOS	0.04172584041953087
trial_1	placebo	191	KG00104055	Biliverdin increased	0.04083866626024246
trial_1	placebo	144	KG00099610	Leukopenia NOS	0.04073890298604965
trial_1	placebo	72	KG00103771	myalgias	0.04016343876719475
trial_1	placebo	38	KG00098066	Binocular vision disorders	0.040114626288414
trial_1	placebo	355	KG00110857	lymphocyte count decreased	0.03931823745369911
trial_1	placebo	131	KG00100948	Urinary tract infection (& [NOS])	0.03917086124420166
trial_1	placebo	147	KG00098000	atelectases	0.03907138109207153
trial_1	placebo	269	KG00100399	pyaemia	0.03804166242480278
trial_1	placebo	282	KG00099309	hypernatraemia	0.03785865381360054
trial_1	placebo	1	KG00099959	Neutropenia NOS	0.037793390452861786
trial_1	placebo	142	KG00100923	Unspecified infectious and parasitic diseases	0.03728866204619408
trial_1	placebo	249	KG00104430	hypoalbuminaemia	0.03691010922193527
trial_1	placebo	132	KG00101045	Gain, Weight	0.03687850758433342
trial_1	placebo	102	KG00097916	anxieties	0.03604963421821594
trial_1	placebo	262	KG00101199	agitation	0.035061612725257874
trial_1	placebo	276	KG00099127	Arrest, Cardiac	0.03505286946892738
trial_1	placebo	396	KG00100373	Embolism, Pulmonary	0.034575723111629486
trial_1	placebo	139	KG00098855	Sinusitis, Ethmoid	0.0340559259057045
trial_1	placebo	154	KG00099686	Lymphopenias	0.03309182822704315
trial_1	placebo	82	KG00097697	abdomen distended	0.0330376997590065
trial_1	placebo	466	KG00101205	fall	0.03219124302268028
trial_1	placebo	288	KG00101223	hypophosphataemia	0.03193710371851921
trial_1	placebo	35	KG00101507	hypomagnesaemia	0.031688790768384933
trial_1	placebo	116	KG00098964	Pain in foot	0.03135327994823456
trial_1	placebo	341	KG00101472	Gamma-glutamyltransferase increased	0.03099292702972889
trial_1	placebo	36	KG00106434	Vision, Blurring Of	0.030949734151363373
trial_1	placebo	18	KG00098307	Pain, Chest	0.030848585069179535
trial_1	placebo	361	KG00098004	Fibrillation, Atrial	0.030531996861100197
trial_1	placebo	121	KG00099190	haemorrhage	0.0301866065710783
trial_1	placebo	186	KG00101431	creatinine increased	0.030102446675300598
trial_1	placebo	253	KG00100232	Pleural effusion NOS (disorder)	0.02980206161737442
trial_1	placebo	69	KG00100082	Palpitations NOS	0.029332855716347694
trial_1	placebo	164	KG00108827	ileus colon	0.02862500585615635
trial_1	placebo	130	KG00100683	Stomatitis NOS	0.02756202034652233
trial_1	placebo	441	KG00098262	cellulitis nos	0.027274053543806076
trial_1	placebo	234	KG00098669	dysgeusias	0.02694103494286537
trial_1	placebo	97	KG00104198	LIVER ENZYME ELEVATED	0.026928074657917023
trial_1	placebo	356	KG00112623	Infectious Lung Disorders	0.02673536352813244
trial_1	placebo	92	KG00100926	Infections, Upper Respiratory	0.02660188637673855
trial_1	placebo	33	KG00100094	Pancreatitis NOS	0.026386858895421028
trial_1	placebo	75	KG00100195	Dolens, Phlegmasia Alba	0.025725780054926872
trial_1	placebo	31	KG00099872	Infarction, Myocardial	0.024933036416769028
trial_1	placebo	100	KG00097815	alopecias	0.02460729517042637
trial_1	placebo	256	KG00100738	Tachycardia, Sinus	0.024256644770503044
trial_1	placebo	422	KG00101429	Creatine phosphokinase increased	0.024093715474009514
trial_1	placebo	204	KG00098849	Esophagitis, Peptic	0.02356753498315811
trial_1	placebo	242	KG00100855	tremors	0.023392045870423317
trial_1	placebo	268	KG00099557	Heart Failure, Left-Sided	0.023291610181331635
trial_1	placebo	508	KG00108565	blood glucose increased	0.023002218455076218
trial_1	placebo	15	KG00097882	Angina pectoris NOS	0.022872895002365112
trial_1	placebo	286	KG00101110	Retention, Urinary	0.022858425974845886
trial_1	placebo	98	KG00097718	Incised wound, NOS	0.022454572841525078
trial_1	placebo	297	KG00099294	hypercholesterolaemia	0.022314244881272316
trial_2	methyclothiazide	78	KG00099326	Hypertensive diseases	0.1834663450717926
trial_2	methyclothiazide	87	KG00098599	diarrhoea	0.17378847301006317
trial_2	methyclothiazide	189	KG00101580	Alanine aminotransferase increase	0.133098766207695
trial_2	methyclothiazide	177	KG00099299	hyperglycaemia	0.13145799934864044
trial_2	methyclothiazide	123	KG00099351	hypokalaemia	0.11817364394664764
trial_2	methyclothiazide	188	KG00101579	Aspartate aminotransferase increase	0.11181146651506424
trial_2	methyclothiazide	17	KG00097991	Asthenia NOS	0.1094527468085289
trial_2	methyclothiazide	173	KG00098172	Bronchopneumonia NOS	0.1074075773358345
trial_2	methyclothiazide	46	KG00099121	Headache NOS	0.09709885716438293
trial_2	methyclothiazide	9	KG00098432	Confusion NOS	0.0965469628572464
trial_2	methyclothiazide	21	KG00098675	dyspnoea	0.09582971781492233
trial_2	methyclothiazide	20	KG00098540	dehydration	0.09356392174959183
trial_2	methyclothiazide	228	KG00114657	Weight below normal	0.08837125450372696
trial_2	methyclothiazide	37	KG00097696	Cramps, Abdominal	0.08522957563400269
trial_2	methyclothiazide	350	KG00106765	decreased platelet count	0.08409801870584488
trial_2	methyclothiazide	2	KG00100772	thrombocytopaenia	0.08269296586513519
trial_2	methyclothiazide	29	KG00099354	hyponatraemia	0.08205243200063705
trial_2	methyclothiazide	67	KG00098673	Dyspepsia, NOS	0.07863903045654297
trial_2	methyclothiazide	49	KG00099902	nausea with vomiting	0.0780855119228363
trial_2	methyclothiazide	14	KG00097852	Anemia NOS	0.07505201548337936
trial_2	methyclothiazide	193	KG00108982	WHITE BLOOD CELL COUNT DECREASED	0.07463408261537552
trial_2	methyclothiazide	64	KG00097734	Acrodermatitis, NOS	0.06986873596906662
trial_2	methyclothiazide	68	KG00099901	nauseas	0.0689842700958252
trial_2	methyclothiazide	79	KG00100317	Insomnia, Primary	0.06874091923236847
trial_2	methyclothiazide	200	KG00098539	Disorders, Deglutition	0.06516055017709732
trial_2	methyclothiazide	114	KG00098933	fevers	0.06057475879788399
trial_2	methyclothiazide	194	KG00110727	Neutrophil Count Decreased	0.05878191441297531
trial_2	methyclothiazide	179	KG00099342	hypocalcaemia	0.058149635791778564
trial_2	methyclothiazide	77	KG00098450	Constipation NOS	0.05789849907159805
trial_2	methyclothiazide	151	KG00098274	Infarction, Cerebral	0.05732134357094765
trial_2	methyclothiazide	76	KG00100450	Respiratory insufficiency, NOS	0.057153794914484024
trial_2	methyclothiazide	86	KG00098565	Depression, Mental	0.05582801625132561
trial_2	methyclothiazide	104	KG00097963	arthralgias	0.05416206270456314
trial_2	methyclothiazide	126	KG00100076	Pain NOS	0.05359792709350586
trial_2	methyclothiazide	85	KG00098474	coughs	0.05309704318642616
trial_2	methyclothiazide	27	KG00099303	hyperkalaemia	0.05261848866939545
trial_2	methyclothiazide	61	KG00099501	Chronic Kidney Failure	0.05155130848288536
trial_2	methyclothiazide	101	KG00097901	Anorexia NOS	0.05003172159194946
trial_2	methyclothiazide	239	KG00100128	pareses	0.049842718988657
trial_2	methyclothiazide	243	KG00100947	Micturition frequency increased	0.049513667821884155
trial_2	methyclothiazide	180	KG00099363	Hypotension NOS	0.04909190908074379
trial_2	methyclothiazide	96	KG00101679	Unattended death NOS	0.0478878989815712
trial_2	methyclothiazide	30	KG00099500	Acute Kidney Failure	0.047357793897390366
trial_2	methyclothiazide	261	KG00101559	raised alkaline phosphatase	0.04383191466331482
trial_2	methyclothiazide	28	KG00099347	hypoglycaemia	0.04317861422896385
trial_2	methyclothiazide	5	KG00099169	haematuria	0.04174870625138283
trial_2	methyclothiazide	122	KG00099321	Hypersensitivity NOS	0.04172584041953087
trial_2	methyclothiazide	191	KG00104055	Biliverdin increased	0.04083866626024246
trial_2	methyclothiazide	144	KG00099610	Leukopenia NOS	0.04073890298604965
trial_2	methyclothiazide	72	KG00103771	myalgias	0.04016343876719475
trial_2	methyclothiazide	38	KG00098066	Binocular vision disorders	0.040114626288414
trial_2	methyclothiazide	355	KG00110857	lymphocyte count decreased	0.03931823745369911
trial_2	methyclothiazide	131	KG00100948	Urinary tract infection (& [NOS])	0.03917086124420166
trial_2	methyclothiazide	147	KG00098000	atelectases	0.03907138109207153
trial_2	methyclothiazide	269	KG00100399	pyaemia	0.03804166242480278
trial_2	methyclothiazide	282	KG00099309	hypernatraemia	0.03785865381360054
trial_2	methyclothiazide	1	KG00099959	Neutropenia NOS	0.037793390452861786
trial_2	methyclothiazide	142	KG00100923	Unspecified infectious and parasitic diseases	0.03728866204619408
trial_2	methyclothiazide	249	KG00104430	hypoalbuminaemia	0.03691010922193527
trial_2	methyclothiazide	132	KG00101045	Gain, Weight	0.03687850758433342
trial_2	methyclothiazide	102	KG00097916	anxieties	0.03604963421821594
trial_2	methyclothiazide	262	KG00101199	agitation	0.035061612725257874
trial_2	methyclothiazide	276	KG00099127	Arrest, Cardiac	0.03505286946892738
trial_2	methyclothiazide	396	KG00100373	Embolism, Pulmonary	0.034575723111629486
trial_2	methyclothiazide	139	KG00098855	Sinusitis, Ethmoid	0.0340559259057045
trial_2	methyclothiazide	154	KG00099686	Lymphopenias	0.03309182822704315
trial_2	methyclothiazide	82	KG00097697	abdomen distended	0.0330376997590065
trial_2	methyclothiazide	466	KG00101205	fall	0.03219124302268028
trial_2	methyclothiazide	288	KG00101223	hypophosphataemia	0.03193710371851921
trial_2	methyclothiazide	35	KG00101507	hypomagnesaemia	0.031688790768384933
trial_2	methyclothiazide	116	KG00098964	Pain in foot	0.03135327994823456
trial_2	methyclothiazide	341	KG00101472	Gamma-glutamyltransferase increased	0.03099292702972889
trial_2	methyclothiazide	36	KG00106434	Vision, Blurring Of	0.030949734151363373
trial_2	methyclothiazide	18	KG00098307	Pain, Chest	0.030848585069179535
trial_2	methyclothiazide	361	KG00098004	Fibrillation, Atrial	0.030531996861100197
trial_2	methyclothiazide	121	KG00099190	haemorrhage	0.0301866065710783
trial_2	methyclothiazide	186	KG00101431	creatinine increased	0.030102446675300598
trial_2	methyclothiazide	253	KG00100232	Pleural effusion NOS (disorder)	0.02980206161737442
trial_2	methyclothiazide	69	KG00100082	Palpitations NOS	0.029332855716347694
trial_2	methyclothiazide	164	KG00108827	ileus colon	0.02862500585615635
trial_2	methyclothiazide	130	KG00100683	Stomatitis NOS	0.02756202034652233
trial_2	methyclothiazide	441	KG00098262	cellulitis nos	0.027274053543806076
trial_2	methyclothiazide	234	KG00098669	dysgeusias	0.02694103494286537
trial_2	methyclothiazide	97	KG00104198	LIVER ENZYME ELEVATED	0.026928074657917023
trial_2	methyclothiazide	356	KG00112623	Infectious Lung Disorders	0.02673536352813244
trial_2	methyclothiazide	92	KG00100926	Infections, Upper Respiratory	0.02660188637673855
trial_2	methyclothiazide	33	KG00100094	Pancreatitis NOS	0.026386858895421028
trial_2	methyclothiazide	75	KG00100195	Dolens, Phlegmasia Alba	0.025725780054926872
trial_2	methyclothiazide	31	KG00099872	Infarction, Myocardial	0.024933036416769028
trial_2	methyclothiazide	100	KG00097815	alopecias	0.02460729517042637
trial_2	methyclothiazide	256	KG00100738	Tachycardia, Sinus	0.024256644770503044
trial_2	methyclothiazide	422	KG00101429	Creatine phosphokinase increased	0.024093715474009514
trial_2	methyclothiazide	204	KG00098849	Esophagitis, Peptic	0.02356753498315811
trial_2	methyclothiazide	242	KG00100855	tremors	0.023392045870423317
trial_2	methyclothiazide	268	KG00099557	Heart Failure, Left-Sided	0.023291610181331635
trial_2	methyclothiazide	508	KG00108565	blood glucose increased	0.023002218455076218
trial_2	methyclothiazide	15	KG00097882	Angina pectoris NOS	0.022872895002365112
trial_2	methyclothiazide	286	KG00101110	Retention, Urinary	0.022858425974845886
trial_2	methyclothiazide	98	KG00097718	Incised wound, NOS	0.022454572841525078
trial_2	methyclothiazide	297	KG00099294	hypercholesterolaemia	0.022314244881272316
